Search research articles
Contact Us
Filters
Showing results (91-100 of 125) with videos related to
Page
of 13
Sort By:
Alcoholism, Clinical and Experimental Research
|
December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients
P Bedossa, T Poynard, A Abella, et al.
British Journal of Cancer
|
February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis
F Janot, J Klijanienko, A Russo, et al.
Oncology
|
July 4, 2006
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial
M Ducreux, O Bouche, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications
F Andre, D Grunenwald, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
J-C Soria, A Mauguen, M Reck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2007
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
A Italiano, C Massard, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1993
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma
P Rougier, J J Zarba, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias, M Bonnay, J M Puizillou, et al.
Journal of Hepatology
|
August 8, 1998
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC
G Pelletier, M Ducreux, F Gay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
M Ducreux, A Adenis, J-P Pignon, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 125) with videos related to
Sort By:
Page
of 13
Alcoholism, Clinical and Experimental Research
|
December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients
P Bedossa, T Poynard, A Abella, et al.
British Journal of Cancer
|
February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis
F Janot, J Klijanienko, A Russo, et al.
Oncology
|
July 4, 2006
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial
M Ducreux, O Bouche, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications
F Andre, D Grunenwald, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
J-C Soria, A Mauguen, M Reck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2007
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
A Italiano, C Massard, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1993
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma
P Rougier, J J Zarba, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias, M Bonnay, J M Puizillou, et al.
Journal of Hepatology
|
August 8, 1998
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC
G Pelletier, M Ducreux, F Gay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
M Ducreux, A Adenis, J-P Pignon, et al.
Page
of 13